- NAYA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
NAYA Biosciences (NAYA) CORRESPCorrespondence with SEC
Filed: 13 Jul 20, 12:00am
INVO BIOSCIENCE, INC.
5582 BROADCAST COURT
Sarasota, florida 32240
July 13, 2020
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | INVO Bioscience, Inc. |
|
| Registration Statement on Form S-1 |
|
| File No. 333-239762 |
Ladies and Gentlemen:
INVO Bioscience, Inc. (the “Company”) hereby requests, pursuant to Rule 461 under the Securities Act of 1933, as amended, that the above-referenced registration statement be accelerated to 4:00 p.m., Eastern Time, on Wednesday July 15, 2020, or as soon thereafter as practicable.
Very truly yours, |
| |
|
| |
INVO BIOSCIENCE, INC. |
| |
|
| |
|
| |
By: | /s/ Steven Shum |
|
Steven Shum |
| |
Chief Executive Officer |
| |
|
|
|